Polymorphisms in PARP, IL1B, IL4, IL10, C1INH, DEFB1, and defa4 in meningococcal disease in three populations

Shock

Volumn 34, Issue 1, 2010, Pages 17-22

  Emonts, Marieke ^a   Vermont, Clementien L ^a   Houwing Duistermaat, Jeanine J ^b   Haralambous, Elene ^c   Gaast De Jongh, Christa E ^d   Hazelzet, Jan A ^a   Faust, Saul N ^e   Betts, Helen ^c   Hermans, Peter W M ^d   Levin, Michael ^c   De Groot, Ronald ^d  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Imperial College London St Mary's Campus ^*  (United Kingdom)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

genetic variation; immune response; infectious disease; Meningococcal infection; pediatric; transmission disequilibrium test

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SERINE PROTEINASE INHIBITOR;

ADOLESCENT; ALLELE; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; PEDIATRICS; PRESCHOOL CHILD; PROMOTER REGION; SCHOOL CHILD; UNITED KINGDOM;

ALPHA-DEFENSINS; BETA-DEFENSINS; COMPLEMENT C1 INACTIVATOR PROTEINS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-4; MENINGOCOCCAL INFECTIONS; POLY(ADP-RIBOSE) POLYMERASES; POLYMORPHISM, GENETIC;

EID: 77953899144     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181ce2c7d     Document Type: Article

References (39)

1. Trotter C, Samuelsson S, Perrocheau A, de Greeff S, de Melker H, Heuberger S, Ramsay M: Ascertainment of meningococcal disease in Europe. Euro Surveill 10:247-250, 2005.
2. Emonts M, Hazelzet JA, de Groot R, Hermans PW: Host genetic determinants of Neisseria meningitidis infections. Lancet Infect Dis 3:565-577, 2003.
3. Zhao C, Wang I, Lehrer RI: Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 396:319-322, 1996.
4. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schroder JM, Wang JM, Howard OM, et al.: Beta-defensins: linking innate and adaptive immunity through dendritic and T cell ccr6. Science 286:525-528, 1999.
5. Duits LA, Ravensbergen B, Rademaker M, Hiemstra PS, Nibbering PH: Expression of beta-defensin 1 and 2 mrna by human monocytes, macrophages and dendritic cells. Immunology 106:517-525, 2002.
6. Singh A, Bateman A, Zhu QZ, Shimasaki S, Esch F, Solomon S: Structure of a novel human granulocyte peptide with anti-ACTH activity. Biochem Biophys Res Commun 155:524-529, 1988.
7. den Brinker M, Joosten KF, Liem O, de Jong FH, Hop WC, Hazelzet JA, van Dijk M, Hokken-Koelega AC: Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. J Clin Endocrinol Metab 90:5110-5117, 2005.
8. Fijen CA, Kuijper EJ, te Bulte MT, Daha MR, Dankert J: Assessment of complement deficiency in patients with meningococcal disease in the Netherlands. Clin Infect Dis 28:98-105, 1999.
9. Matsushita M, Thiel S, Jensenius JC, Terai I, Fujita T: Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J Immunol 165:2637-2642, 2000.
10. Kaplan AP, Joseph K, Silverberg M: Pathways for bradykinin formation and inflammatory disease. J Allergy Clin Immunol 109:195-209, 2002.
11. Cai S, Dole VS, Bergmeier W, Scafidi J, Feng H, Wagner DD, Davis AE 3rd: A direct role for c1 inhibitor in regulation of leukocyte adhesion. J Immunol 174:6462-6466, 2005.
12. Emonts M, de Jongh CE, Houwing-Duistermaat JJ, van Leeuwen WB, de Groot R, Verbrugh HA, Hermans PW, van Belkum A: Association between nasal carriage of Staphylococcus aureus and the human complement cascade activator serine protease c1 inhibitor (C1INH) valine vs. methionine polymorphism at amino acid position 480. FEMS Immunol Med Microbiol 50:330-332, 2007.
13. Rosenwasser LJ, Borish L: Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10). Am J Respir Crit Care Med 156:S152-S155, 1997.
14. Nakashima H, Miyake K, Inoue Y, Shimizu S, Akahoshi M, Tanaka Y, Otsuka T, Harada M: Association between IL-4 genotype and IL-4 production in the Japanese population. Genes Immun 3:107-109, 2002.
15. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV: An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1-8, 1997.
16. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150, 2003.
17. Masutani M, Nakagama H, Sugimura T: Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease. Cell Mol Life Sci 62:769-783, 2005.
18. Lockett KL, Hall MC, Xu J, Zheng SL, Berwick M, Chuang SC, Clark PE, Cramer SD, Lohman K, Hu JJ: The adprt v762a genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res 64:6344-6348, 2004.
19. Peters MJ, Ross-Russell RI, White D, Kerr SJ, Eaton FE, Keengwe IN, Tasker RC, Wade AM, Klein NJ: Early severe neutropenia and thrombocy-topenia identifies the highest risk cases of severe meningococcal disease. Pediatr Crit Care Med 2:225-231, 2001.
20. Slater A, Shann F, Pearson G: PIM2: a revised version of the Paediatric Index of Mortality. Intensive Care Med 29:278-285, 2003.
21. Thomson AP, Sills JA, Hart CA: Validation of the Glasgow Meningococcal Septicemia Prognostic Score: a 10-year retrospective survey. Crit Care Med 19:26-30, 1991.
22. Goldstein B, Giroir B, Randolph A: International Pediatric Sepsis Consensus Conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6:2-8, 2005.
23. De Kleijn ED, Joosten KF, Van Rijn B, Westerterp M, De Groot R, Hokken-Koelega AC, Hazelzet JA: Low serum cortisol in combination with high adrenocorticotrophic hormone concentrations are associated with poor outcome in children with severe meningococcal disease. Pediatr Infect Dis J 21:330-336, 2002.
24. De Kleijn ED, De Groot R, Hack CE, Mulder PG, Engl W, Moritz B, Joosten KF, Hazelzet JA: Activation of protein c following infusion of protein c concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study. Crit Care Med 31:1839-1847, 2003.
25. Van der Kaay DC, De Kleijn ED, De Rijke YB, Hop WC, De Groot R, Hazelzet JA: Procalcitonin as a prognostic marker in meningococcal disease. Intensive Care Med 28:1606-1612, 2002.
26. Vermont CL, den Brinker M, Kakeci N, de Kleijn ED, de Rijke YB, Joosten KF, de Groot R, Hazelzet JA: Serum lipids and disease severity in children with severe meningococcal sepsis. Crit Care Med 33:1610-1615, 2005.
27. Kornelisse RF, Hazelzet JA, Hop WC, Spanjaard L, Suur MH, van der Voort E, de Groot R: Meningococcal septic shock in children: clinical and laboratory features, outcome, and development of a prognostic score. Clin Infect Dis 25:640-646, 1997.
28. Pollack MM, Ruttimann UE, Getson PR: Pediatric Risk of Mortality (PRISM) Score. Crit Care Med 16:1110-1116, 1988.
29. Horvath S, Xu X, Laird NM: The family based association test method: strategies for studying general genotype-phenotype associations. Eur J Hum Genet 9:301-306, 2001.
30. Nagelkerke NJ, Hoebee B, Teunis P, Kimman TG: Combining the transmission disequilibrium test and case-control methodology using generalized logistic regression. Eur J Hum Genet 12:964-970, 2004.
31. Lin PI, Vance JM, Pericak-Vance MA, Martin ER: No gene is an island: the flip-flop phenomenon. Am J Hum Genet 80:531-538, 2007.
32. Beghe B, Barton S, Rorke S, Peng Q, Sayers I, Gaunt T, Keith TP, Clough JB, Holgate ST, Holloway JW: Polymorphisms in the interleukin-4 and interleukin-4 receptor alpha chain genes confer susceptibility to asthma and atopy in a Caucasian population. Clin Exp Allergy 33:1111-1117, 2003.
33. Choi EH, Lee HJ, Yoo T, Chanock SJ: A common haplotype of interleukin-4 gene il4 is associated with severe respiratory syncytial virus disease in korean children. J Infect Dis 186:1207-1211, 2002.
34. Hoebee B, Rietveld E, Bont L, Oosten M, Hodemaekers HM, Nagelkerke NJ, Neijens HJ, Kimpen JL, Kimman TG: Association of severe respiratory syn-cytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor ! polymorphisms. J Infect Dis 187:2-11, 2003.
35. Aroeira LS, Martinez AC: The role of il-4 in the staphylococcal enterotoxin bYtriggered immune response: increased susceptibility to shock and deletion of CD8V"8+ T cells in IL-4 knockout mice. Eur J Immunol 29:1397-1405, 1999.
36. O'Dwyer MJ, Mankan AK, Stordeur P, O'Connell B, Duggan E, White M, Kelleher DP, McManus R, Ryan T: The occurrence of severe sepsis and septic shock are related to distinct patterns of cytokine gene expression. Shock 26: 544-550, 2006.
37. Read RC, Cannings C, Naylor SC, Timms JM, Maheswaran R, Borrow R, Kaczmarski EB, Duff GW: Variation within genes encoding interleukin-1 and the interleukin-1 receptor antagonist influence the severity of meningococcal disease. Ann Intern Med 138:534-541, 2003.
38. Read RC, Camp NJ, di Giovine FS, Borrow R, Kaczmarski EB, Chaudhary AG, Fox AJ, Duff GW: An interleukin-1 genotype is associated with fatal outcome of meningococcal disease. J Infect Dis 182:1557-1560, 2000.
39. van der Pol WL, Huizinga TW, Vidarsson G, van der Linden MW, Jansen MD, Keijsers V, de Straat FG, Westerdaal NA, de Winkel JG, Westendorp RG: Relevance of Fcgamma receptor and interleukin-10 polymorphisms for me-ningococcal disease. J Infect Dis 184:1548-1555, 2001.